Eagle Pharmaceuticals Stock Market Value
| EGRX Stock | USD 4.55 0.06 1.30% |
| Symbol | Eagle |
Eagle Pharmaceuticals Price To Book Ratio
Is Eagle Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.85 | Revenue Per Share 19.684 | Quarterly Revenue Growth (0.13) | Return On Assets 0.0663 |
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eagle Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eagle Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eagle Pharmaceuticals.
| 03/24/2024 |
| 04/23/2024 |
If you would invest 0.00 in Eagle Pharmaceuticals on March 24, 2024 and sell it all today you would earn a total of 0.00 from holding Eagle Pharmaceuticals or generate 0.0% return on investment in Eagle Pharmaceuticals over 30 days. Eagle Pharmaceuticals is related to or competes with ANI Pharmaceuticals, Phibro Animal, Deciphera Pharmaceuticals, Prestige Brand, Collegium Pharmaceutical, Silver Spike, and Regencell Bioscience. Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to t... More
Eagle Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eagle Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eagle Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.05 | |||
| Information Ratio | 0.0098 | |||
| Maximum Drawdown | 23.1 | |||
| Value At Risk | (7.92) | |||
| Potential Upside | 8.0 |
Eagle Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eagle Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eagle Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eagle Pharmaceuticals historical prices to predict the future Eagle Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0254 | |||
| Jensen Alpha | 0.0329 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0102 | |||
| Treynor Ratio | 0.106 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eagle Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eagle Pharmaceuticals Backtested Returns
We consider Eagle Pharmaceuticals moderately volatile. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 8.0E-4, which denotes the company had a 8.0E-4% return per unit of risk over the last 3 months. We have found thirty technical indicators for Eagle Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Eagle Pharmaceuticals' Downside Deviation of 5.05, mean deviation of 4.11, and Coefficient Of Variation of 3713.89 to check if the risk estimate we provide is consistent with the expected return of 0.0043%. The firm shows a Beta (market volatility) of 1.23, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Eagle Pharmaceuticals will likely underperform. Eagle Pharmaceuticals right now shows a risk of 5.28%. Please confirm Eagle Pharmaceuticals downside variance, and the relationship between the total risk alpha and daily balance of power , to decide if Eagle Pharmaceuticals will be following its price patterns.
Auto-correlation | -0.52 |
Good reverse predictability
Eagle Pharmaceuticals has good reverse predictability. Overlapping area represents the amount of predictability between Eagle Pharmaceuticals time series from 24th of March 2024 to 8th of April 2024 and 8th of April 2024 to 23rd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eagle Pharmaceuticals price movement. The serial correlation of -0.52 indicates that about 52.0% of current Eagle Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.52 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Eagle Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eagle Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eagle Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eagle Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eagle Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eagle Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eagle Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eagle Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eagle Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eagle Pharmaceuticals Lagged Returns
When evaluating Eagle Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eagle Pharmaceuticals stock have on its future price. Eagle Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eagle Pharmaceuticals autocorrelation shows the relationship between Eagle Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eagle Pharmaceuticals.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eagle Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eagle Pharmaceuticals' short interest history, or implied volatility extrapolated from Eagle Pharmaceuticals options trading.
Pair Trading with Eagle Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eagle Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Eagle Stock
| 0.48 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Eagle Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eagle Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eagle Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eagle Pharmaceuticals to buy it.
The correlation of Eagle Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eagle Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eagle Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eagle Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Eagle Pharmaceuticals Correlation, Eagle Pharmaceuticals Volatility and Eagle Pharmaceuticals Alpha and Beta module to complement your research on Eagle Pharmaceuticals. For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Eagle Stock analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Eagle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.